Leaflet ASORIAN 0.415mg / 2.595mg / 103.800mg / ml cutaneous solution

Product code:
W01868001
Quantity:
1
Indicated for:
inflammatory dermatoses
Route of administration:
cutaneous
Substance:
fluocinolone acetonide + allantoin + dimethyl sulfoxide (anti-inflammatory agents)
ATC
D05AXN1 — Dermatologicals | Antipsoriatics | Antipsoriatics for topical use | Other antipsoriatics for topical use

Precautions:

Glaucoma warning

Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Hyperglycemia

Hyperglycemia

This medicine may increase blood sugar.

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

The combination of fluocinolone acetonide, allantoin, and dimethyl sulfoxide is used to treat skin inflammations and irritations such as dermatitis, eczema, or other skin conditions. Fluocinolone acetonide is a corticosteroid that reduces inflammation and itching, allantoin promotes skin regeneration, and dimethyl sulfoxide increases the absorption of active substances and has an anti-inflammatory effect.

The medication is applied locally as a cream or ointment to the affected area, as directed by your doctor. It is important not to exceed the recommended duration or frequency of treatment to avoid the side effects of corticosteroids.

Side effects may include local irritation, dry skin, or, rarely, allergic reactions. Prolonged use or application on large areas may lead to skin thinning or systemic absorption of the active substances, with possible general side effects.

The combination of fluocinolone acetonide, allantoin, and dimethyl sulfoxide is effective in quickly relieving skin symptoms, but should be used with caution and only as recommended by your doctor to avoid complications.

General data about ASORIAN 0.415mg / 2.595mg / 103.800mg / ml

Substance:
fluocinolone acetonide + allantoin + dimethyl sulfoxide
Date of latest medicines list:
01-04-2024
Product code:
W01868001
Concentration:
0.415mg / 2.595mg / 103.800mg / ml
Pharmaceutical form:
cutaneous solution
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
BIOFARM S.A. - ROMANIA
Holder:
BIOFARM S.A. - ROMANIA
Number:
12175/2019/01
Shelf life:
2 years